Clinical trial
PARTNER 3 Trial - Mitral Valve in Valve
NCT03193801 · Edwards Lifesciences, Industry · Active, not recruiting
Key facts
| NCT number | NCT03193801 |
|---|---|
| Title | PARTNER 3 Trial - Mitral Valve in Valve |
| Official title | PARTNER 3 Trial - SAPIEN 3 Transcatheter Heart Valve Implantation in Patients With a Failing Mitral Bioprosthetic Valve |
| Lead sponsor | Edwards Lifesciences, Industry |
| Status | Active, not recruiting |
| Study type | Interventional |
| Conditions | Mitral Valve Insufficiency, Mitral Valve Disease, Mitral Valve Regurgitation, Heart Failure |
| Intervention type | Device |
| Interventions | Edwards SAPIEN 3 transcatheter valve, Model 9600TFX |
| Enrollment | 53 |
| Start date | Feb 1, 2018 |
| Primary completion | Aug 16, 2022 |
| Completion | Aug 1, 2031 |
| First posted | Jun 21, 2017 |
| Last update posted | Nov 5, 2025 |
| Countries | Australia, Brazil, United States |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: